GPS for the brain: could neuronavigation boost stroke rehab?
NCT ID NCT07284017
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a brain-mapping system (neuronavigation) to guide magnetic stimulation (rTMS) helps stroke patients with arm weakness recover better than standard positioning. Thirty adults who had a stroke 2 weeks to 6 months ago will receive 10 sessions over 2 weeks. Researchers will measure arm function and treatment accuracy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
repetitive transcranial magnetic stimulation (rTMS) guided by neuronavigation
What this could lead to
If it works, this could point toward a more precise and effective way to help stroke survivors regain arm movement.
What could go wrong
This is a small, early-stage trial with only 30 people. The improvement may be small or no better than standard rTMS. Results may not apply to all stroke patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••